Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORA17 is a non-coding RNA (snoRNA) that functions in the modification and processing of other small nuclear RNAs. SnoRNAs like SNORA17 are important for the chemical modification of ribosomal RNAs and small nuclear RNAs, typically guiding pseudouridylation (the conversion of uridine to pseudouridine) during RNA biogenesis. LOC124900297 is not a protein, enzyme, transporter, receptor, or canonical drug target, but rather plays a housekeeping role in RNA metabolism and processing[1][3]. ENSG00000212589 is not a protein, not a receptor, not an enzyme, and not recognized as a druggable or therapeutic target. No drugs, mechanism of action, or safety concerns are described in the literature for this entity. If you are seeking a protein-coding gene or a classical drug target, this entity does not qualify as such[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORA17 (SNORA17).